As mentioned earlier, there is an urgent need for the development of novel antibiotics targeting S. aureus. Fortunately, a number of new agents active against MRSA and other Gram-positive ...

The antibiotic teixobactin—developed a decade ago by Northeastern University professors Kim Lewis and Slava Epstein in ...

When that happens, your infection will be said to be antibiotic resistant, and your physician will have to prescribe a different drug to combat it. MRSA: The Spread of Drug Resistance In fact ...

Antibiotics are ubiquitous within the ... Methicillin-resistant staphylococcus aureus (MRSA) is probably the best known superbug. First observed in 1960, MRSA continued to increase slowly in ...

Doctors claim they are seeing more and more cases of MRSA in children. The bacteria are resistant to most common antibiotics, so they have to turn to a small handful of stronger ones. But doctors ...

Methicillin-resistant Staphylococcus aureus (MRSA), infections are prevalent among hospitalized people, or those taking antibiotics for long periods. But, of late, MRSA is becoming increasingly ...

The US accounts for 80% to 90% of the total market for anti-MRSA antibiotics, so FDA approval is key to growing ceftobiprole's revenues, currently a minor part of its CHF 131 million ($137 million ...

Given the growing antibiotic resistance crisis, novel ways to target bacterial infections are becoming increasingly important. One potential strategy is to manipulate bacterial genes at the ...